Suchergebnisse - "Thompson, B Taylor"

PubPharm (47)

1

PROLONGED MECHANICAL VENTILATION IN ACUTE RESPIRATORY DISTRESS SYNDROME

enthalten in: Shock (Augusta, Ga.) | 2024

von Andrianopoulos, I. | Giannakoulis, V. | Papoutsi, E. | +4

2

Simvastatin in Critically Ill Patients with Covid-19

enthalten in: The New England journal of medicine | 2023

von REMAP-CAP Investigators | Hills, T. | Lorenzi, E. | +172

3

Lopinavir/ritonavir for treatment of non-hospitalized patients with COVID-19 : a randomized clinical trial

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Kaizer, A. | Shapiro, N. | Wild, J. | +13

4

Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension

enthalten in: The New England journal of medicine | 2023

von National Heart, L. | Shapiro, N. | Douglas, I. | +125

CommentIn: Ann Emerg Med. 2023 Apr;81(4):513-515. - PMID 36948690

5

Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19 : a randomised, double-blind, phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2022

von ACTIV-3–Therapeutics for Inpatients with COVID-19 (TICO) Study Group | Ginde, A. | Paredes, R. | +98

CommentIn: Lancet Respir Med. 2022 Oct;10(10):928-930. - PMID 35817073

6

The prognostic value of early measures of the ventilatory ratio in the ARDS ROSE trial

enthalten in: Critical care (London, England) | 2022

von Monteiro, A. | Vangala, S. | Wick, K. | +8

7

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO) : a randomised controlled trial

enthalten in: The Lancet. Infectious diseases | 2022

von ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group | Self, W. | Sandkovsky, U. | +98

CommentIn: Lancet Infect Dis. 2022 May;22(5):567-569. - PMID 34953521

8

Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial

enthalten in: Annals of internal medicine | 2022

von ACTIV-3/TICO Bamlanivimab Study Group | Lundgren, J. | Grund, B. | +151

9

A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19

enthalten in: The New England journal of medicine | 2021

von ACTIV-3/TICO LY-CoV555 Study Group | Lundgren, J. | Grund, B. | +144

CommentIn: N Engl J Med. 2021 Feb 3;:. - PMID 33534967

10

Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 : A Randomized Clinical Trial

enthalten in: JAMA | 2020

von Self, W. | Semler, M. | Leither, L. | +98

CommentIn: JAMA. 2020 Dec 1;324(21):2161-2162. - PMID 33165507

1
2
3
4
5
Nächster »
[5]